The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2023

Filed:

Mar. 08, 2019
Applicant:

Pharmablock Sciences (Nanjing), Inc., Jiangsu, CN;

Inventors:

Liu Liu, Ann Arbor, MI (US);

Jin Li, Jiangsu, CN;

Minmin Yang, Jiangsu, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 401/06 (2006.01); C07D 471/04 (2006.01); A61P 35/04 (2006.01); C07D 401/14 (2006.01); C07D 471/08 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61P 35/04 (2018.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01);
Abstract

The present invention provides PRMT5 inhibitors of Formula (I), wherein Ris a non-hydrogen monovalent group; W is a direct bond or —NH—; T, U, and V are independently of each other selected from C and N; Ris H or a halo; m is 1 or 2; X is a carbon, a nitrogen, or an oxygen; Y is C or N; Z is a direct bond or a carbon; Ris H, a non-hydrogen monovalent group, an oxo group, a bivalent spiro ring-forming group, or a bivalent bridge-forming group; n is 1 or 2; and Formula (II) stands for a single bond or a double bond. Pharmaceutical products comprising the PRMT5 inhibitors and use thereof in treating proliferative disorders such as cancer, metabolic disorders, blood disorders, autoimmune diseases, and inflammatory diseases are also provided.


Find Patent Forward Citations

Loading…